What is targeted cancer therapy?
Targeted cancer therapy is a specific method of treatment for cancers, by identifying and targeting the cancer-causing factors (hallmarks) in the particular cancer. Targeted therapy medications do not directly kill the cancer cells, but work on the cellular level to stop their growth and prevent cancer from spreading to other parts of the body.
Cancer target therapy consists of two forms of medications:
- Small molecule drugs: Minute particles that attach to proteins on the cell surface or get into the cell and modify its activity.
- Monoclonal antibodies: Lab-produced antibodies that are too large to get inside the cell, but work on the cell surface to activate the immune system.
What is cancer?
Cancer is a unique group of diseases caused by uncontrolled growth of aberrant cells. Cancers arise due to mutations in the growth-modulating genes in some cells. Genetic mutations may be inherited or caused by environmental factors, certain viral infections, or sometimes a combination of factors that cannot be precisely pinpointed.
How does cancer spread?
Human cell growth is a tightly regulated process dictated by inter-related cell-signaling mechanisms. Normal cells grow, divide into two daughter cells, migrate to different parts of the body, and mature into cells with specific functions (differentiation).
Normal cells also die in an orderly manner (apoptosis) when they grow old, get damaged or because they are simply no longer needed. Cancer cells don’t follow these rules. Cancer cells evade apoptosis and keep growing nonstop. Cancers can originate anywhere in the body and spread by processes known as invasion and metastasis.
What are invasion and metastasis in cancer?
Many cancers form an abnormal lump of tissue growth called tumors. Tumors grow by subverting normal cell processes to sprout new blood vessels, and recruiting nearby normal cells to aid in their growth. Tumors are termed to be malignant when they invade and metastasize.
Normal cells stop growing when they come into contact with the nearby cells, in a process known as contact inhibition. Tumor cells continue to grow and overrun their natural space, crowding out the normal cells and starving them of oxygen and nutrients. The tumor cells then penetrate the neighboring tissue to continue growing, which is known as invasion.
Metastasis is the process by which cancer cells migrate and spread to other parts of the body. Human tissue is made up of primarily two types of cells:
- Epithelial cells: Cells that adhere to each other in layers and are also anchored to a supportive structure known as extracellular matrix. Epithelial cells form a layer of protective covering over the body and all the organs and glands.
- Mesenchymal cells: Mesenchymal cells are solitary stem cells produced in the bone marrow, which can migrate and mature into any type of connective tissue, blood vessels and other tissue cells as required, during growth or wound healing.
Normal epithelial cells cannot survive detached from the extracellular matrix, and undergo apoptosis. The dead cells are cleared away by immune cells known as phagocytes which engulf and digest them. Abnormal epithelial cells (skin cancers) spread through the skin and lymphatic system.
Tumor cells develop the ability to transform into abnormal mesenchymal cells and disengage from the extracellular matrix. The stem-cell like tumor cells get into the bloodstream or the lymphatic system, migrate to other parts of the body, and start forming new tumor growths.
What are the targeted therapies for invasion and metastasis?
There are several proteins and cellular signals that tumor cells employ for promoting invasion and metastasis. Many therapies targeting invasion and metastasis are in development.
Transforming growth factor beta (TGF-B) is a protein (cytokine) secreted by all types of white blood cells. TGF-B family has many proteins that play multiple roles in regulating cell growth, differentiation, migration, apoptosis and extracellular matrix production.
TGF-B proteins play a role in inhibiting growth in the initial stages of tumor, by releasing inflammatory cytokines. Genetic mutations in the cancer cells disrupt the TGF-B signaling pathways and negate the inhibitory effect. TGF-B also suppresses immune response to promote healing which helps the tumor evade immune surveillance and grow.
Other roles of TGF-B include promotion of epithelial-to-mesenchymal transition, formation of new blood vessels (neo-angiogenesis) and extracellular matrix, and migration, which enable the tumor cells to invade other tissue and metastasize. Many types of cancer have been found to secrete increased levels of TGF-B.
Both small molecule inhibitors and monoclonal antibody therapies targeting TGF-B inhibition are in clinical trials.
Insulin-like growth factor (IGF) is a signaling pathway that regulates fetal growth. IGF-1, IGF-2 and insulin are hormone molecules that attach to their respective protein receptors (IGF-1R, IGF-2R, IR) on cell surfaces and activate them. IGF-1R regulates the growth of skeleton and other organs in the fetus, while IR regulates the glucose metabolism in the cell.
Both IGF-1R and IR stimulate cell division and have been found to promote metastasis in many types of cancers. Several IGF-1R inhibitors and IR inhibitors are in various stages of clinical trials.
The proto-oncogene c-SRC encodes SRC protein, a type of intracellular protein known as non-receptor tyrosine kinase (NRTK). A proto-oncogene is a gene that has a high potential for causing cancer if it mutates into an oncogene.
SRC kinases play an important role in cell division, adhesion, migration, invasion and metastasis. High levels of SRC proteins have been found in many types of cancers.
Following are the FDA-approved small molecule inhibitor therapies targeting the SRC protein:
- Dasatinib: Approved for two types of invasive/metastatic cancers:
- Bosutinib: approved for chronic, accelerated or blast-phase Philadelphia positive chronic myeloid leukemia
The above two therapies are also being evaluated for treating other metastatic cancers. Many other small molecule inhibitors are in clinical trials.
The focal adhesion kinase (FAK) is a type of non-receptor protein kinase that regulates signaling pathways essential for cell adhesion, migration, proliferation and death. FAK also acts as a scaffold for connecting the cells to the extracellular matrix.
When stimulated by growth factors, FAK activates many other proteins including the SRC protein, promoting metastasis. Excessive levels of FAK are found in many types of cancer. Currently, small molecule inhibitors of FAK are in early-phase of trials.
There are several proteins and cellular signals that cancerous or malignant tumor cells employ for promoting invasion and metastasis. Targeted cancer therapies are in development to chemically hinder invasion and metastasis. Targeted therapy, in general, by identifying and targeting cancer-causing factors. Targeted therapy medications do not directly kill the cancer cells, but work on the cellular level to stop their growth and prevent cancer from spreading to other parts of the body.
Multimedia: Slideshows, Images & Quizzes
Understanding Cancer: Metastasis, Stages of Cancer, and More
Learn the basics about cancer including types, causes, how it spreads, symptoms and signs, stages and treatment options. Read...
Signs of Cancer in Women: Symptoms You Can't Ignore
Colon and stomach cancer symptoms can surprise women but can be treated if detected early. Learn about breast cancer signs and...
Cancer: Guide to Leukemia
Learn about the common types and stages of leukemia, who gets it, symptoms, tests, treatments, and more. People with blood cancer...
Cancer-Fighting Foods: Resveratrol, Green Tea, and More
Experts have praised certain foods for their ability to reduce cancer risks. Learn which foods and eating strategies may help...
Top 10 Cancers Quiz
Take this quiz to learn the causes of cancer. Get the facts about the causes, symptoms, and treatments for the world's most...
Cancer: Visual Guide to Thyroid Cancer
Find out the symptoms of thyroid cancer, and learn how to treat it after you get a diagnosis.
Cancer: Does This Cause Cancer?
Everything gives you cancer, right? Not really. WebMD's slide show tells you about the research into cancer and cell phones,...
Cancer: How to Lower and Cut Your Risk of Cancer
About a third of all cases of cancer can be prevented. Find out how to lower your chances of getting it.
Cancer: Symptoms of Common Cancers in Men
Can men get breast cancer? Cancer symptoms men need to watch out for include skin changes, difficulty swallowing, rapid weight...
Cancer: Cancer 'Remedies' That Don't Work
You may have read about an all-natural cure for cancer. While many therapies are helpful, some aren't worth your time or money....
Related Disease Conditions
Cancer is a disease caused by an abnormal growth of cells, also called malignancy. It is a group of 100 different diseases, and is not contagious. Cancer can be treated through chemotherapy, a treatment of drugs that destroy cancer cells.
Cancer Risk Factors and Causes
Though it's difficult to say why some people develop cancer while others don't, research shows that certain risk factors increase a person's odds of developing cancer. These risk factors include growing older, family history of cancer, diet, alcohol and tobacco use, and exposure to sunlight, ionizing radiation, certain chemicals, and some viruses and bacteria.
At What Stage of Cancer is Chemotherapy Used?
The decision to use chemotherapy may vary depending on the aggressiveness, stage and type of cancer. Usually, chemotherapy may be used for all stages in most cancer types. Chemotherapy is a type of medicine or combination of medications that is used to treat or kill cancer cells.
What Type of Cancer Makes You Very Tired?
Extreme and recurrent tiredness is one of the common symptoms of most types of cancers. Tiredness is usually considered a warning sign of cancer progressing. Tiredness related to cancers usually does not get better with adequate rest or sleep.
Prostate Cancer Treatment: Chemotherapy, Bone-Targeted and Immune Therapy
Doctors may introduce chemotherapy and immune therapy if other measures fail to cure a case of prostate cancer. However, unlike with other forms of cancer, chemotherapy isn’t the first choice for early prostate cancer. Immune therapy uses the body's own immune system to attack the prostate tumor, while bone-targeted therapy aims to preserve bone and prevent metastasis.
Which Is the Deadliest Cancer?
Lung cancer is considered to be the most deadly cancer. More people die from lung cancer each year than from breast, colorectal and prostate cancer combined.
Cancer pain is a common experience that may result from the disease, treatment, or diagnostic procedure. Check out the center below for more medical references on cancer, including multimedia (slideshows, images, and quizzes), related disease conditions, treatment and diagnosis, medications, and prevention or wellness.
What Are the Top Ten Cancers?
Lung cancer is the number one killer cancer in the world. It is the most common cause of cancer-related deaths in both men and women.
Treatment & Diagnosis
Medications & Supplements
- Targeted Therapy: What Is Replicative Immortality in Cancer?
- Targeted Therapy: What Are Targeted Antiangiogenic Cancer Therapies?
- Targeted Therapy: What Is the Function of A Tumor Suppressor Gene?
- Targeted Therapy: What Is Apoptosis in Cancer Cells?
- dasatinib, Sprycel
- Targeted Therapy: What Drugs Target the Tumor Microenvironment?
Health Solutions From Our Sponsors
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.